Breaking News
December 9, 2018 - Deprescribing could help manage polypharmacy in older adults
December 9, 2018 - FDA Warns of Rare Stroke Risk With MS Drug Lemtrada (Alemtuzumab)
December 9, 2018 - Feds say heroin, fentanyl remain biggest drug threat to US
December 9, 2018 - Eliminating microglia can reverse some aspects of stress sensitization, study shows
December 9, 2018 - New genetic insight could help treat rare debilitating heart and lung condition
December 9, 2018 - MiRagen Therapeutics Announces Final Safety, Biodistribution and Clinical Efficacy Data From Phase 1 Cobomarsen Clinical Trial in Patients With Mycosis Fungoides
December 9, 2018 - Work with your doctor to weigh pros, cons of treatment options for hyperthyroidism
December 9, 2018 - CWRU researcher secures $14.6 million funding for genetic study into Alzheimer’s disease
December 9, 2018 - High intensity statin treatment and adherence could save more lives
December 9, 2018 - Surgery patients use only 1/4 of prescribed opioids, and prescription size matters
December 9, 2018 - AXT offers Phi Optics upgrade to QPI systems for inverted light microscopes
December 9, 2018 - New booklet could help improve conditions of young pupils with albinism
December 9, 2018 - Few Physicians Work in Practices That Use Telemedicine
December 9, 2018 - Older Adults and Oral Health
December 9, 2018 - Health utility values improve after septorhinoplasty
December 9, 2018 - New EU-funded project provides insight into how the brain develops
December 9, 2018 - Expanded use of tele-emergency services can help strengthen rural hospitals
December 9, 2018 - Infections in the Young May Be Tied to Risk for Mental Illness: Study
December 9, 2018 - Profile: Native Hawaiians and Pacific Islanders
December 9, 2018 - Snoring poses greater cardiac risk to women
December 9, 2018 - Researcher takes further steps in understanding how and why cute aggression occurs
December 9, 2018 - Researchers create new light-activated tools for controlling neurons
December 9, 2018 - Spinal cord injury disrupts the body’s internal clock, study shows
December 9, 2018 - Babies recognize nested structures similar to our grammar
December 9, 2018 - UT Austin researcher receives $2.5 million CZI grant for neurodegenerative disease research
December 9, 2018 - Sleep problems found to be prevalent and increasing among college students
December 9, 2018 - Study reveals why some children are susceptible to the effects of maltreatment
December 9, 2018 - Study investigates influence of different opioids on driving performance
December 9, 2018 - Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating JZP-258 for the Treatment of Idiopathic Hypersomnia
December 9, 2018 - Eliminating microglia prevents heightened immune sensitivity after stress
December 9, 2018 - Boys with social difficulties are at greatest risk of early substance use
December 9, 2018 - ‘Wrong’ connective tissue cells linked to worse prognosis in breast cancer patients
December 8, 2018 - Chronic, refractory schizophrenia patients benefit from targeted cognitive training
December 8, 2018 - Advertising in kids’ apps more prevalent than parents may realize
December 8, 2018 - New way to trace the transmission histories of rare genetic diseases
December 8, 2018 - ASH: A+CHP Bests CHOP for Peripheral T-Cell Lymphoma
December 8, 2018 - Results of pediatric genomic epilepsy tests often reclassified
December 8, 2018 - New way of controlling HIV latency to completely eradicate the virus
December 8, 2018 - Phasefocus to showcase the Livecyte 2 at ASCB
December 8, 2018 - KHN’s ‘What the Health?’ Is health spending the next big political issue?
December 8, 2018 - Mussels take in microplastic pollution fibers and flush most of them out again
December 8, 2018 - AHA: How to Stop Smoking … for Good
December 8, 2018 - Scientists overturn odds to make Parkinson’s discovery
December 8, 2018 - Health benefits of producing marula vinegar
December 8, 2018 - Failure of critical cellular energy sensor responsible for CKD progression, study finds
December 8, 2018 - Ethnicity can be reliable indicator of gut microbiota diversity
December 8, 2018 - Safe Sleep for Baby | NIH News in Health
December 8, 2018 - Study looks at ways technology can support nutritional needs of Parkinson’s patients
December 8, 2018 - Infant milk allergy is being overdiagnosed say experts
December 8, 2018 - Graphene may one day be used to test for ALS
December 8, 2018 - Houston Methodist launches real-time website to track flu cases
December 8, 2018 - RedHill Announces Positive Top-Line Results from Confirmatory Phase 3 Study with Talicia for H. pylori Infection
December 8, 2018 - A way to measure obesity and health beyond BMI
December 8, 2018 - New diagnostic tools may help identify breast cancer patients who could benefit from targeted therapies
December 8, 2018 - Duke-NUS researchers highlight possible role of bioaerosol sampling in pandemic surveillance
December 8, 2018 - Study quantifies links between alcohol, drug use and violent deaths
December 8, 2018 - Mothers’ stress levels at conception linked to child’s response to life challenges at age 11
December 8, 2018 - MIT researchers develop antimicrobial peptides from South American wasp’s venom
December 8, 2018 - Obesity prevention among low-income, diverse preschool-aged children and parents
December 8, 2018 - Mount Sinai researcher awarded $2.5 million to advance understanding of neurodegenerative diseases
December 8, 2018 - CZI announces funding for open-source software efforts to improve image analysis in biomedicine
December 8, 2018 - New book encompasses the vast history of reproduction
December 8, 2018 - Low-income women in Texas are not receiving contraception after childbirth, study shows
December 8, 2018 - Study expands knowledge about sexuality and gender gaps in political attitudes
December 8, 2018 - Drug reduces hot flash frequency, improves quality of life in breast cancer survivors
December 8, 2018 - Imaging, Biopsy Often Still Needed After Mastectomy
December 8, 2018 - Physical Activity Guidelines for Americans: 2nd edition
December 8, 2018 - Machine learning can improve chemical toxicity prediction
December 8, 2018 - Researchers explore why and how Mediterranean diet may mitigate cardiovascular risk
December 8, 2018 - Multigene test is a helpful decision making tool in breast cancer treatment, study shows
December 8, 2018 - New EZ-2 centrifugal evaporator to safely remove solvents from cytotoxic drug preparations
December 8, 2018 - UMGCCC uses Gammapod radiotherapy to treat breast cancer patients
December 8, 2018 - Men with inflammatory bowel disease have higher prostate cancer risk
December 8, 2018 - Newly developed molecules may provide more reliable relief for people with autoimmune diseases
December 8, 2018 - Exercise program during adjuvant breast cancer treatment may provide cardiovascular benefits
December 8, 2018 - Acutely injured deceased-donor kidneys are suitable for transplant, study suggests
December 8, 2018 - Researchers find two connective tissue cells to be linked to worse prognosis of breast cancer
December 8, 2018 - VCU researchers test vaccine against opioid abuse
December 8, 2018 - An App, Your Fingernail — and Anemia Screening Is Done
December 8, 2018 - New study offers hope for patients suffering from a rare form of blindness
EMBO’s long-term fellowships support advanced research by funding postdoctoral scientists

EMBO’s long-term fellowships support advanced research by funding postdoctoral scientists

image_pdfDownload PDFimage_print

Committed to scientific excellence, since the 1960s, the European Molecular Biology Organization (EMBO) has helped thousands of early-career scientists through its fellowship programme. Typically awarded for two-year periods, EMBO’s long-term fellowships support advanced research and training by funding postdoctoral scientists through spells in other European countries or, when justified, further afield.

Between 2001 and 2010, applications for EMBO fellowships more than doubled, creating a situation in which co-funding was needed to meet demand. Subsequently, the EMBO successfully applied for funding from the EU’s Marie Skłodowska-Curie Actions programme, leading to the establishment of its long-term fellowship co-fund, LTFCOFUND2013.

The fund has enabled the EMBO to increase the number of its transnational fellowships and improve fellowship conditions, thereby furthering the development of European research.

In 2015, from a total of 1 549 applications, the LTFCOFUND2013 was used to provide fellowships for 252 young postdoctoral life scientists (or EMBO fellows) during a crucial phase in their careers. This figure is about 25 % higher than that for 2016, when no co-funded money was available for the EMBO.

‘Through LTFCOFUND2013, EMBO funded early postdoctoral researchers in most areas of life sciences with a focus on molecular biology,’ says David del Álamo, head of the EMBO’s fellowships programme in Germany. ‘However, the EMBO defines molecular biology in the broadest possible terms, encompassing research into the mechanisms of life at all levels, from single molecules to organisms and ecosystems.’

The EMBO funds applications in areas as diverse as molecular biology of disease and biomedicine, neuroscience, plant biology, ecology and evolution, genomic and computational biology, and structural biology and biophysics, he adds.

Developing careers

Funding under LTFCOFUND2013 is only used to cover fellows’ needs. As del Álamo says: ‘No money is spent on overheads, research-related costs or any other administrative or bureaucratic expenses. The EMBO aims to maximise the investment in researchers themselves, helping them develop their careers and therefore advancing science in Europe and beyond.’

In terms of career development, EMBO fellows have the chance to attend lab leadership courses during their fellowship periods to help them move into group leader roles shortly afterwards.

A boost for science

As regards advancing science, EMBO funding helped enhance medical knowledge of the genetic changes and mutations associated with some 7 000 tumours across 19 types of human cancer. Another EMBO-funded study of 46 children and 30 adults in Sweden advanced knowledge of human brain development. This could feed into the development of treatments for neurological disorders such as autism, dyslexia and attention deficit hyperactivity disorder.

EMBO fellowships have also helped further understanding of areas including Alzheimer’s disease, heart conditions, injuries to the central nervous system, leukaemia, and breast, lung and kidney cancer.

At the end of their fellowship, all fellows are invited to the EMBO fellows’ meeting in Heidelberg, Germany. A similar gathering is organised every two years in the USA for fellows living in North America. According to del Álamo, this represents ‘an excellent opportunity not only to present their scientific results but also for networking with other fellows’.

Source:

http://ec.europa.eu/research/infocentre/article_en.cfm?id=/research/headlines/news/article_18_10_01_en.html?infocentre&item=Infocentre&artid=49695

Tagged with:

About author

Related Articles